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adenosine 5Ј-triphosphate-sensitive K ϩ channel; adenosine 5Ј-monophosphate-activated protein kinase; phosphatidylinositol 3-kinase; electrophysiology INSULIN RECEPTORS located in the ventromedial hypothalamus (VMH) regulate energy homeostasis (3, 13, 33) . Mice with neuron-specific disruption of the insulin receptor gene (NIRKO mice) exhibit hyperphagia, increased adiposity, hyperinsulinemia, and insulin resistance, consistent with type 2 diabetes mellitus (5, 30) . Similar effects are noted in VMH-lesioned rats (14, 15) . Moreover, microinjection of insulin directly into the VMH significantly reduces the firing rate of sympathetic nerves that supply interscapular brown adipose tissue. Destruction of VMH neurons via kainic acid injection blocks the inhibitory effects of insulin on sympathetic firing rate (31a, 32) . These results suggest that dysfunctional VMH insulin signaling impairs sympathetic nervous system activity and is correlated with the development of type 2 diabetes mellitus.
The central effects of insulin on food intake and energy balance are mediated by the phosphoinositol 3-kinase (PI3K) signaling pathway. The PI3K inhibitors wortmannin and LY-294002 block the inhibitory effect of intracerebroventricular insulin on food intake and body weight gain in rats (45) . The PI3K signaling pathway also mediates the effects of insulin on VMH glucose-sensing neurons (40) . That is, wortmannin blocks insulin-induced activation of the ATP-sensitive K ϩ (K ATP ) channel and subsequent inhibition of neuronal activity of VMH glucose-excited (GE) neurons exposed to 10 mM glucose. These data suggest that VMH glucose-sensing neurons may play a role in the central effects of insulin on energy homeostasis.
The VMH possesses two subtypes of glucose-sensing neurons that directly sense changes in extracellular glucose. GE neurons increase and glucose-inhibited (GI) neurons decrease their action potential frequency, membrane potential, and input resistance as glucose increases (38, 39) . Glucose closes the K ATP channel on GE neurons, whereas it opens a chloride channel on GI neurons (38) . Both GE and GI neurons respond to hormonal signals of peripheral energy homeostasis [e.g., insulin and leptin (6, 43) ]. Previous studies of VMH glucosesensing neurons utilized extracellular glucose concentrations (e.g., 10 mM or higher) that exceed physiological brain glucose levels. Thus, it has been difficult to ascertain the physiological role of VMH glucose-sensing neurons. However, work from our laboratory has established that VMH GE and GI neurons in brain slices are sensitive to changes in glucose between 0.1 and 2.5 mM (38, 43) , suggesting that they are physiologically relevant brain glucose sensors.
Insulin also opens the K ATP channel on VMH GE neurons in 2.5 mM glucose. However, in contrast to what was observed in 10 mM glucose, insulin-induced K ATP channel activation in 2.5 mM glucose was not sufficient to alter neuronal activity (43) . The interaction between insulin and glucose concentration is potentially relevant. That is, insulin may not have a profound effect on action potential frequency at a particular glucose concentration within the physiological range. However, insulin-induced activation of the K ATP channel may blunt the effect of lowering glucose on K ATP channel activity and thus on neuronal activity. We hypothesize that this will reduce the ability of GE neurons to sense decreased glucose. A reduction in the sensitivity of the brain to small glucose decreases is consistent with the role of insulin as a central satiety factor. Thus, this study will test the hypothesis that insulin blunts the response of VMH GE neurons in brain slices to physiological glucose decreases as a result of K ATP channel activation.
METHODS
Preparation of brain slices. Male 14-to 21-day-old SpragueDawley rats were housed at the New Jersey Medical School animal facility, with their dams in a controlled temperature of 22-23°C and on a 12:12-h light-dark cycle. Animals were maintained on Purina Rat Chow 5001 and water ad libitum. On the day of the experiment, rats were anesthetized with 50 mg/kg pentobarbital and transcardially perfused. Brains were then rapidly removed and placed in an ice-cold slushy oxygenated perfusion solution. Sections (350 m) through the hypothalamus were maintained at 32°C in oxygenated artificial cerebrospinal fluid (ACSF) composed of the following (in mM): 126 NaCl, 1.9 KCl, 1.2 KH 2PO4, 26 NaHCO3, 2.5 glucose, 9 MgCl2, and 0.3 CaCl2; osmolarity was adjusted to ϳ300 mOsm with sucrose, pH 7.4. Slices were then transferred to normal oxygenated ACSF (2.4 mM CaCl2, 1.3 mM MgCl2) for the remainder of the experiment. All procedures were approved by the Institutional Animal Care and Use Committee at the New Jersey Medical School.
Electrophysiology: whole cell recordings in brain slices. Viable neurons were visualized and studied under infrared differential-interference contrast microscopy using a Leica DMLFS microscope equipped with a ϫ40 long-working distance water-immersion objective. Current-and voltage-clamp recordings from VMH neurons were performed using an Axopatch-1D amplifier (Axon Instruments, Foster City, CA). Data were simultaneously digitized at 5 kHz (Digidata 1320A; Axon Instruments) and analyzed using pCLAMP 9.2 software. During recording, brain slices were perfused at 6 ml/min with normal oxygenated ACSF. Borosilicate pipettes (1.4 -3.5 M⍀; Sutter Instruments, Novato, CA) were filled with an intracellular solution containing (in mmol/l) 128 K-gluconate, 10 KCl, 4 KOH, 10 HEPES, 4 MgCl 2, 0.5 CaCl2, and 5 EGTA, pH 7.2. Osmolarity was adjusted to 290 -300 mOsm with sucrose. Amphotericin B was included in the patch pipette to establish the perforated patch recording configuration (final concentration 240 g/ml, stock 60 mg/ml DMSO). The junction potential between the bath and the patch pipette was nulled before the formation of a gigaohm seal. Membrane potential and action potential frequency were allowed to stabilize for 10 -15 min after formation of a gigaohm seal to allow for the amphotericin B to perforate the membrane. Neurons with access resistance that exceeds 40 M⍀ were rejected. Input resistance was calculated from the change in membrane potential in response to small, 500-ms hyperpolarizing pulses (Ϫ10 to Ϫ20 pA) given every 3 s, as described previously. The reversal potential was calculated from the change in membrane current in response to voltage steps from Ϫ120 to ϩ60 mV from a holding potential of Ϫ60 mV. Steady-state currents were determined by measuring data points within the last 5 ms of the 200-ms voltage pulses. GE neurons are identified as those that decrease their action potential frequency, membrane potential, and input resistance with a decrease in extracellular glucose from 2.5 to 0.1 mM; GI neurons do the converse. Experimental manipulation of extracellular glucose levels and chemicals added to the ACSF are described in the figure legends. All chemicals were obtained from Sigma (St. Louis, MO).
Statistical analysis. All data were expressed as means Ϯ SE. Statistical analysis was performed using Student's t-test or one-way analysis of variance. P Ͻ 0.05 was considered statistically significant.
RESULTS

Localization of VMH GE neurons.
Whole cell patch clamp recordings were used to characterize 359 VMH neurons with regard to their glucose and insulin sensitivity. When recordings were made predominately in the lateral arcuate nucleus (ARC) within the VMH, 3.2% (4 of 124 neurons) were GE neurons, whereas none were GI neurons. In contrast, when recordings were made along the ventrolateral border of the ventromedial nucleus (VL-VMN) within the VMH, 19.6% (46 of 235 neurons) were GE neurons. GI neurons made up Ͻ1% of the neurons in the VL-VMN (1 of 235 neurons; Fig. 1 ). These studies indicate that the densest population of GE neurons is found in the VL-VMN. For this reason, we focused on VL-VMN GE neurons for the present study.
Evaluation of the insulin concentration-response relationship. When insulin (5 nM) was added to 5 mM glucose, the action potential frequency of VL-VMN GE neurons decreased by 55 Ϯ 10% (n ϭ 9, P Ͻ 0.05). However, the addition of insulin to 2.5 or 0.1 mM glucose had no significant effect on the action potential frequency of VL-VMN GE neurons (2.5 mM glucose: 6 Ϯ 3%, n ϭ 15, P Ͼ 0.05; 0.1 mM glucose: 0 Ϯ 0%, n ϭ 6, P Ͼ 0.05). In contrast, insulin significantly decreased membrane potential and input resistance of GE neurons in all three glucose concentrations (Fig. 2) . However, the inhibitory effect of insulin on membrane potential and input resistance of GE neurons in 2.5 and 0.1 mM glucose was significantly attenuated compared with that in 5 mM glucose (P Ͻ 0.05; Fig. 2 ). The effects of insulin persisted during the whole treatment period and were readily reversible with removal of insulin from the perfusion solution.
Previous studies have shown that the effects of insulin (0.5-500 nM) on VMH GE neurons were independent of insulin concentration (40, 43) . Therefore, we evaluated lower insulin concentrations to determine the threshold for the inhibitory effect of insulin on GE neurons in physiological brain glucose concentrations. Because insulin had no effect on action potential frequency in 2.5 and 0.1 mM glucose, we calculated the insulin concentration-response relationship using the percent change in input resistance. Input resistance is also a sensitive measure of neuronal excitability and reflects changes in ion channel activity. There was no significant difference between the effect of insulin on the input resistance of GE neurons in 2.5 mM glucose and that in 0.1 mM glucose (Fig.  2) ; thus, these data were combined to generate the concentration-response relationship for insulin. Using insulin concentrations from 5 pM to 300 nM, we found that the half-maximal effective concentration (EC 50 ) for insulin on input resistance of VL-VMN GE neurons in 2.5 or 0.1 mM glucose was 3.3 nM (Fig. 3) .
K ATP channel activation mediates insulin's effects on VL-VMN GE neurons. Current-voltage relationships show that the insulin-induced current in VL-VMN GE neurons reverses at approximately Ϫ96 Ϯ 5.9 mV (adjusted to a Ϫ20-mV junction potential; n ϭ 9) in all three glucose concentrations (Fig. 4) . This is near the theoretical K ϩ equilibrium potential of Ϫ99 mV in our solutions. In addition, the K ATP channel blocker tolbutamide abolished insulin's effects in 5, 2.5, and 0.1 mM glucose (Fig. 5, A-C) . Current-voltage relationships for the effects of insulin in the presence and absence of tolbutamide reversed at the theoretical K ϩ equilibrium potential (Fig. 5D ). These data are consistent with earlier reports that insulin opens the K ATP channel on GE neurons in 10 and 2.5 mM glucose (40, 43) . Finally, tolbutamide inhibited the effects of both 50 pM and 5 nM insulin (data not shown), suggesting that K ATP channel activation mediates the effects of insulin on VL-VMN GE neurons in all insulin concentrations.
Insulin suppresses the ability of VL-VMN GE neurons to sense decreased glucose. Decreasing extracellular glucose from 2.5 to 0.1 mM decreased the action potential frequency of VL-VMN GE neurons by 71 Ϯ 5% (n ϭ 19, P Ͻ 0.05; Fig. 6 ). In contrast, when glucose was lowered in the presence of 5 nM insulin, action potential frequency was decreased by only 34 Ϯ 8% (n ϭ 9, P Ͻ 0.05; Fig. 6 ). As shown in Fig. 7 , the decrease in input resistance and membrane potential in response to decreased glucose was similarly attenuated in the presence of insulin.
The effect of insulin on the glucose sensitivity of VL-VMN GE neurons was reversed in the presence of the PI3K inhibitor wortmannin (10 nM). That is, when glucose was lowered from 2.5 to 0.1 mM in the presence of insulin and wortmannin, action potential frequency was decreased by 69 Ϯ 9% (n ϭ 8, P Ͻ 0.05; Fig. 6 , lower middle trace). This is not significantly different from that observed in response to a decrease in extracellular glucose alone (P Ͼ 0.05). Similar results were noted for membrane potential and input resistance (Fig. 7) . The response to decreasing extracellular glucose in the presence of wortmannin was not significantly different compared with a decrease in glucose alone (Fig. 7) .
In contrast to the effects of wortmannin, the MAPK inhibitor PD-98059 (50 M) did not alter the effect of insulin on the glucose sensitivity of VL-VMN GE neurons (Figs. 6 and 7). Fig. 3 . Insulin concentration-response relationship for %change in IR in VL-VMN GE neurons in brain slices. There was no significant difference in the effect of 5 pM to 300 nM insulin on IR in 2.5 or 0.1 mM glucose; thus, these data points were combined. The EC50 for insulin was 3.3 nM. . Insulin causes significant hyperpolarization and decreases in action potential frequency (APF) in 5 (n ϭ 9) but not 2.5 (n ϭ 25) or 0.1 mM glucose (G) (n ϭ 6; A and B). However, insulin significantly decreased IR and membrane potential (MP) in all 3 glucose concentrations (C and D). The effect of insulin on IR and MP in 5 mM glucose was greater than that in 2.5 or 0.1 mM glucose (columns with different letters are statistically different; *significantly different from 0% change, P Ͻ 0.05).
That is, decreasing glucose from 2.5 to 0.1 mM in the presence of insulin decreased action potential frequency to a similar extent independent of the presence of PD-98059 in the perfusion solution (insulin, Ϫ34 Ϯ 8%; insulin ϩ PD-98059, Ϫ20 Ϯ 11%, n ϭ 6, P Ͼ 0.05; Fig. 6 ; upper middle and bottom traces, respectively). As shown in Fig. 7 , there was no significant difference in input resistance and membrane potential in response to decreased extracellular glucose with insulin in the presence and absence of PD-98059.
AMP-activated protein kinase (AMPK) signaling does not appear to play a role in glucose sensing in VL-VMN GE neurons. Decreasing glucose from 2.5 to 0.1 mM in the presence of the specific AMPK inhibitor compound C (10 M; Ref. 18) decreased action potential frequency by 78 Ϯ 9% (n ϭ 4, P Ͻ 0.05; Fig. 8A , middle trace). This was not significantly different from the decrease in action potential frequency when glucose was decreased in the absence of compound C (71 Ϯ 5%, n ϭ 19, P Ͻ 0.05; Fig. 8A, top trace) . As shown in Fig. 8 , B and C, top, there was no significant difference in input resistance and membrane potential in response to decreased glucose in the presence and absence of compound C. Furthermore, there was no significant difference in the action potential frequency of VL-VMN GE neurons in the presence and absence of the AMPK activator 5-aminoimidazole-4-carboxamide (0.5 mM) in 2.5 mM glucose (Fig. 8A, bottom trace) . Similar results were seen for input resistance and membrane potential (Fig. 8, B and C, bottom) .
The effects of insulin on VL-VMN GE neurons were direct, as indicated by the persistence of response in the presence of the selective voltage-dependent Na ϩ channel blocker tetrodotoxin (TTX; 300 nM, n ϭ 5; Fig. 9 ). Finally, insulin had no significant effect on input resistance, action potential frequency, or membrane potential in non-glucose-sensing neurons in the VL-VMN (n ϭ 22; data not shown). 
DISCUSSION
Previous studies have shown that peripheral signals of energy balance, such as insulin and leptin, regulate the activity of hypothalamic glucose-sensing neurons (40, 41, 43) . We show here that insulin blunts the response of GE neurons to glucose decreases. These data are consistent with the role of insulin as a central satiety factor (34, 35) . That is, if VL-VMN GE neurons are important for initiating and/or maintaining signals of energy sufficiency, it would be inappropriate for these neurons to become inhibited by small decreases in glucose associated with meal-to-meal oscillations. Rather, in the presence of normal insulin levels, VL-VMN GE neurons are inhibited only during severe glucose deficits that would compromise brain function.
Numerous studies indicate that the VL-VMN is necessary for signals of energy sufficiency to be correctly interpreted by the brain (21) . VMH lesions have been associated with obesity (14) . In particular, specific lesions, which included the VL-VMN and the capsule surrounding the VMN, cause the most profound obesity (15, 21) . Later studies further support a critical role for this region in the regulation of energy balance. The neurotoxin gold thioglucose, which causes obesity, destroys neurons specifically in the VL-VMN and the "cell-poor" region between the VMN and ARC (22) . Moreover, many VMH-efferent projections to other brain regions involved in metabolic regulation arise from the VL-VMN (21). The data above suggest that the VL-VMN supports catabolic processes. It is noteworthy that we find the greatest concentration of GE neurons in the VL-VMN. The regulation of VL-VMN GE neurons by insulin and glucose is consistent with the hypothesis that the VL-VMN is important for the integration of signals of energy sufficiency. Moreover, our data showing that insulin regulates the glucose sensitivity of VL-VMN GE neurons support a role for these neurons in the maintenance of energy homeostasis.
Our observation that insulin did not change the action potential frequency of VL-VMN GE neurons in 2.5 mM glucose appears to contradict the present literature. Spanswick and colleagues (40, 41) demonstrated that insulin abolished action potentials and caused profound inhibition of VMH GE neurons by opening the K ATP channel. However, Spanswick and colleagues (40, 41) , like many others (1, 2, 25, 27, 28, 29) , evaluated GE neurons in 10 mM glucose (or higher). These extracellular glucose concentrations were based on the assumption that brain glucose levels were equal to those found in the periphery. Since these earlier experiments were completed, a number of studies have been carried out that indicate that brain glucose levels are much lower than those in the blood (8, 23, 36, 37) . In fact, during peripheral energy sufficiency, VMH glucose levels range from 1.5 to 2.5 m (8, 36, 37). Thus, it was necessary to reevaluate the effects of insulin on GE neurons using physiological glucose concentrations.
To this end, we evaluated the effects of insulin in glucose concentrations that would be found in the brain during peripheral euglycemia (2.5 mM), hypoglycemia (0.1 mM), and hyperglycemia (5 mM) (36, 37). As Spanswick et al. (40) observed in 10 mM glucose, we found that insulin also decreased the membrane potential and action potential frequency of VL-VMN GE neurons in 5 mM glucose. This was associated with a decrease in input resistance, suggesting that an ion channel opened. The insulin-activated current reversed at the 
K
ϩ equilibrium potential and was blocked by the K ATP channel blocker tolbutamide. Thus, insulin inhibited VL-VMN GE neurons in 5 mM glucose by opening the K ATP channel, as occurs in 10 mM glucose (40) . Insulin also opened the K ATP channel on VL-VMN GE neurons in 2.5 and 0.1 mM glucose, as indicated by decreased input resistance, reversal at the K ϩ equilibrium potential, and blockade with tolbutamide. Thus, our data show that insulin opens the K ATP channel on VL-VMN GE neurons regardless of glucose concentration.
However, the magnitude of the effect of insulin on input resistance of VL-VMN GE neurons was inversely correlated with glucose concentration. That is, the insulin-induced decrease in input resistance was significantly attenuated in 2.5 and 0.1 mM glucose compared with that in 5 mM glucose. This indicates that the effect of insulin on the K ATP channel current was diminished in lower glucose concentrations. In fact, insulin-induced K ATP channel activation in 2.5 and 0.1 mM glucose was insufficient to alter action potential frequency. Although insulin does not modify action potentials in physiological glucose, its effects on input resistance and K ATP channel activity are highly significant in terms of regulating the function of VL-VMN GE neurons. One of the primary functions of "nonsynaptic" K ϩ channels is to regulate the excitability or responsiveness of neurons to other stimuli (16) . Thus, in the presence of insulin, the cellular (input) resistance of GE neurons is lower. When cellular resistance is lower, the magnitude of the voltage change in response to a given presynaptic input must be greater to exert the same effect on membrane potential and action potential frequency as would be observed when cellular resistance is higher. These data suggest that, in the presence of insulin, VL-VMN GE neurons are less responsive to presynaptic input, whether it is excitatory or inhibitory.
Alterations in glucose sensitivity are another very important consequence of the effect of insulin on VL-VMN GE neurons in physiological glucose concentration. We show here that insulin blunts the response of VL-VMN GE neurons to glucose decreases. This hypothesis is further supported by the obser- vation that there was no significant difference in the effect of insulin in 2.5 and 0.1 mM glucose. We hypothesize that these data indicate that the effect of insulin is mediated by two distinct populations of K ATP channels on GE neurons, those that are sensitive to physiological changes in extracellular glucose and those that are not (Fig. 10 ). This hypothesis is based on our observation that insulin significantly increases K ATP channel activation in 0.1 mM glucose. This suggests that some K ATP channels on VL-VMN GE neurons are sensitive to insulin but not to changes in extracellular glucose. If all K ATP channels were sensitive to physiologically relevant changes in extracellular glucose levels, they would be maximally open in 0.1 mM glucose and thus insensitive to further activation by insulin. This hypothesis is further supported by our observation that insulin activated K ATP channels on VL-VMN GE neurons in 5 mM glucose to a greater extent than in 0.1 mM. These results are consistent with previously published data showing that lactate administration closes K ATP channels on GE neurons even when increases in extracellular glucose cause no further effect (39) . Colocalization of K ATP channels with glycolytic enzymes at the plasma membrane, as seen in cardiac and intestinal epithelial cells (9, 44) , may account for the existence of multiple populations of K ATP channels. Such colocalization could render these K ATP channels sensitive to changes in extracellular glucose, since cytosolic ATP levels are well buffered (9) .
Multiple K ATP channel populations raise the possibility that the effects of insulin and decreased glucose on K ATP channels are additive. If so, it suggests that insulin attenuates the effect of decreased glucose by "washing out" the effect of decreased glucose on K ATP channel activation. Our data do not support this hypothesis for the following reasons. The effect of decreased glucose from 2.5 to 0.1 mM on input resistance and membrane potential of VL-VMN GE neurons (Fig. 7) is greater than the effect of insulin in 5 mM glucose (Fig. 2) . This might be a consequence of the use of the EC 50 for insulin rather than a maximal concentration. However, the effect of decreasing glucose from 2.5 to 0.1 mM on input resistance is also greater than the maximal effect of insulin in 2.5 mM glucose (Fig. 3) . Moreover, the decreased membrane potential and input resistance observed with insulin in 2.5 mM glucose combined with the further decrease in these parameters when glucose is subsequently lowered to 0.1 mM in the presence of insulin is still smaller than observed when glucose is lowered from 2.5 to 0.1 mM in the absence of insulin. Taken together, our data point toward an interaction between insulin and glucose metabolism. Reports that insulin increases neuronal glucose transporter 3 (42) and hypothalamic glucose transporter 4 translocation (11) as well as pyruvate dehydrogenase activity (18) support this hypothesis. Thus, insulin would have opposing effects on K ATP channel activation (Fig. 10) . On the one hand, insulin directly opens both populations of K ATP channels; however, insulin also increases ATP production, leading to closure of glucose-sensitive K ATP channels. The latter effect of insulin may explain the attenuated the response of GE neurons to decreased glucose in the presence of insulin. Future studies are required to test this hypothesis.
Our results showing that PI3K mediates insulin activation of the K ATP channel are consistent with the literature concerning the role of the PI3K pathway in insulin signaling in the regulation of energy status (34, 35, 45) . Insulin is also linked to the MAPK and AMPK signaling pathways. For example, inhibition of the MAPK pathway blocked insulin-induced sympathoactivation in brown adipose tissue (31) . However, like Spanswick et al. (40) , our results show that administration of the MAPK inhibitor PD-98059 had no effect on insulin action in VL-VMN GE neurons. Insulin has also been reported to decrease hypothalamic AMPK activity (24) . However, we found that neither AMPK activation nor inhibition altered the activity or glucose sensitivity of VL-VMN GE neurons. Thus, it is highly unlikely that AMPK inhibition mediates the effect of insulin on VL-VMN GE neurons. These data suggest that insulin alters the activity of VL-VMN GE neurons via PI3K but not MAPK-or AMPK-dependent mechanisms.
Finally, although we evaluated glucose sensitivity of VL-VMN GE neurons in the presence and absence of insulin, these neurons are unlikely to be exposed to insulin absence in vivo. The studies herein are a necessary first step to determine the effects of insulin on the glucose sensitivity of VL-VMN GE neurons. This enables comparison with previous studies of glucose-sensing neurons in which glucose-sensing neurons are evaluated in the absence of basal hormonal and nutrient signals of peripheral energy homeostasis (e.g., insulin, leptin, free fatty ϩ (KATP) channels on GE neurons. Two subpopulations of KATP channels exist, one that is colocalized with glycolytic enzymes and thus sensitive to changes in extracellular glucose and another that is not. Glucose is transported into neurons via the glucose transporter 3 (GLUT3). Glucokinase (GK) catalyzes the first step in glycolysis in GE neurons (19) . Decreased extracellular glucose results in decreased levels of intracellular ATP. If glycolytic enzymes are compartmentalized adjacent to KATP channels, decreased ATP levels will open these "glucose-sensitive" KATP channels, allow potassium (K) efflux, and inhibit GE neurons. Insulin may have opposing effects on glucose-sensitive KATP channels. First, insulin binds to its receptor, phosphorylates the insulin receptor subunit (IRS), activates PI3K, and opens both the glucose-sensitive and -insensitive populations of KATP channels. However, in addition to direct effects on KATP channel activation, insulin may also close glucose-sensitive KATP channels by increasing neuronal glucose uptake (11, 42) and stimulating glycolysis (18) . The net effect of insulin on VL-VMN GE neurons is to blunt the response to decreased glucose. SUR1, sulfonylurea receptor; Kir6.2, pore-forming subunit of the KATP channel; Glu-6-P, glucose 6-phosphate. acids). However, it is now critical to begin to evaluate these neurons in an in vitro "estimate" of the physiological extracellular brain milieu. For example, it will be important to evaluate the effects of leptin and free fatty acids, first singly and then in combination on the glucose sensitivity of VL-VMN GE neurons. It will also be important to determine how pre-to postprandial fluctuations in insulin levels affect the glucose sensitivity of VL-VMN GE neurons, although this will be a difficult task since physiological brain insulin levels are not yet known.
In conclusion, insulin regulates not only the activity but the glucose sensitivity of VL-VMN GE neurons. Our data suggest that insulin blunts the response of VL-VMN GE neurons to physiological glucose decreases. These data are consistent with the role of insulin as a satiety factor. That is, inhibition of the VL-VMN leads to a shift in body energy balance that favors decreased energy expenditure. During energy sufficiency, it would not be efficient for neurons in the VL-VMN to be inhibited by small decreases in extracellular glucose associated with meal-to-meal oscillations. However, when peripheral energy stores are low, insulin levels decline. Decreased insulin levels would enhance the response of VL-VMN GE neurons to glucose decreases. Thus, VL-VMN GE neurons would be more likely to be inhibited during daily glucose fluctuations, leading to an overall decrease in the activity of the VL-VMN. Our data lead to the hypothesis that insulin resistance during obesity and type 2 diabetes mellitus enhances the response of VL-VMN GE neurons to decreased glucose. This would lead to signals of glucose or energy deficit during energy sufficiency, which could contribute to the development of these metabolic diseases.
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